Development and Validation of the RSClinN1 Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer Por [email protected] Development and Validation of the RSClinN1 Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer Read More »
Adjuvant chemotherapy in T1abN0 breast cancer with a high 21‑gene recurrence score ( 25) a 10‑year follow‑up in a real‑world cohort Por [email protected] Adjuvant chemotherapy in T1abN0 breast cancer with a high 21‑gene recurrence score ( 25) a 10‑year follow‑up in a real‑world cohort Read More »
Capsular contracture in breast reconstruction: A systematic review and meta-analysis Por [email protected] Capsular contracture in breast reconstruction: A systematic review and meta-analysis Read More »
Impact of Postmastectomy Radiation Therapy in Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction Por [email protected] Impact of Postmastectomy Radiation Therapy in Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction Read More »
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial Por [email protected] De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial Read More »
In‑Breast Tumor Progression During Neoadjuvant Chemotherapy: Impact on and Factors Influencing Distant Recurrence‑Free Survival Por [email protected] In‑Breast Tumor Progression During Neoadjuvant Chemotherapy: Impact on and Factors Influencing Distant Recurrence‑Free Survival Read More »
Immediate Tissue Expander Implant Breast Reconstruction after Salvage Mastectomy for Cancer Recurrence following Lumpectomy Irradiation Por [email protected] Immediate Tissue Expander Implant Breast Reconstruction after Salvage Mastectomy for Cancer Recurrence following Lumpectomy Irradiation Read More »
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2- Negative Early Breast Cancer: Results from the EMBER-2 Study Por [email protected] A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2- Negative Early Breast Cancer: Results from the EMBER-2 Study Read More »
Real‑World Implications of the SOUND Trial Por [email protected] Real‑World Implications of the SOUND Trial Read More »
Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I SPY2 clinical trial Por [email protected] Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I SPY2 clinical trial Read More »
Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast Por [email protected] Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast Read More »
Adjuvant Docetaxel and Cyclophosphamide With or Without Epirubicin for Early Breast Cancer: Final Analysis of the Randomized DBCG 07-READ Trial Por [email protected] Adjuvant Docetaxel and Cyclophosphamide With or Without Epirubicin for Early Breast Cancer: Final Analysis of the Randomized DBCG 07-READ Trial Read More »
